Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.138 USD | +1.47% | +0.95% | -76.61% |
04-08 | Nls Pharmaceutics Ltd. Announces Resignation of Anthony S. Walsh as A Member of the Board of Directors | CI |
04-03 | NLS Pharmaceutics Ltd. announced that it has received $1.75 million in funding | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Eric Konofal
FOU | Founder | 57 | 15-06-09 |
Alexander Zwyer
FOU | Founder | 54 | 15-06-09 |
Director of Finance/CFO | - | 23-05-19 | |
George Apostol
CTO | Chief Tech/Sci/R&D Officer | 51 | 22-09-07 |
David Moskowitz
IRC | Investor Relations Contact | - | - |
Hervé Girsault
PRN | Corporate Officer/Principal | 64 | 16-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Audrey Greenberg
BRD | Director/Board Member | 51 | 23-06-29 |
Alexander Zwyer
FOU | Founder | 54 | 15-06-09 |
Ronald Hafner
FOU | Founder | 60 | 15-06-09 |
Director/Board Member | 55 | 21-06-16 | |
Anthony Walsh
BRD | Director/Board Member | - | 23-06-29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 42,806,136 | 27,083,431 ( 63.27 %) | 3,242,887 ( 7.576 %) | 63.27 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-76.61% | 6.51M | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- NLSP Stock
- Company NLS Pharmaceutics Ltd.